Increased risk of SSEs in bone-only metastatic breast cancer patients treated with zoledronic acid.
Journal of Bone Oncology(2017)
摘要
Bone-only MBC patients are more likely to experience an SSE even after treatment with ZA.
更多查看译文
关键词
b-MBC,BP,CI,ER,HER2,HR,MBC,OR,PgR,SRE,SSE,TN,ZA
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要